ANTIPLATELET THERAPY OF ACUTE CORONARY SYNDROME: CURRENT CAPAB ILITIES

ANTIPLATELET THERAPY OF ACUTE CORONARY SYNDROME: CURRENT CAPAB ILITIES

Dual antiplatelet therapy (acetylsalicylic acid and platelet P2Y12 receptor antagonist) is a standard component of treatment of any type of acute coronary syndrome, independently of perfusion and the chosen treatment strategy. Due to certain limitations of clopidogrel as the 2nd component of dual an...

Full description

Bibliographic Details
Main Authors: E. V. Konstantinova, М. Yu. Gilyarov, N. А. Shostak, D. A. Anichkov
Format: Article
Language:Russian
Published: ABV-press 2018-07-01
Series:Klinicist
Subjects:
acute coronary syndrome
dual antiplatelet therapy
percutaneous coronary intervention
prasugrel
ticagrelor
clopidogrel
platelet activation
randomized clinical study
meta-analysis
real clinical practice
Online Access:https://klinitsist.abvpress.ru/Klin/article/view/335

Internet

https://klinitsist.abvpress.ru/Klin/article/view/335

Similar Items